Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-146-2 | CAS number: 1306-19-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- March - December 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Version 25 June 2018
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Cadmium oxide
- EC Number:
- 215-146-2
- EC Name:
- Cadmium oxide
- Cas Number:
- 1306-19-0
- Molecular formula:
- CdO
- IUPAC Name:
- oxocadmium
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Product name: Cadmium oxide
- Physical state: solid (in the powder form), Red-brown
- Purity: 99.8% CdO
i.e. 87.4% Cd
- Lot No.:CDOF78170174
- Expiration date: 22 October 2020
- Storage condition of test material: Controlled room temperature (15-25°C, ≤70% relative humidity)
Constituent 1
- Specific details on test material used for the study:
- Name: Cadmium oxide
Batch/Lot number: CDOF78170174
CAS number: 1306-19-0
Description: Red-brown solid (in the powdered form)
Purity: 99.8%
Expiry date: 22 October 2020
Storage conditions: Controlled room temperature (15-25°C, ≤70% relative humidity)
Safety precautions: Enhanced safety precautions (half mask at least with P3 filter cartridge, nitrile gloves, lab coat) will be applied considering the supplied safety datasheet to assure personnel health and safety.
As agreed with the Sponsor, no correction for purity of the test item will be applied.
Test animals / tissue source
- Species:
- chicken
- Strain:
- other: ROSS 308
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: commercial abattoir - TARAVIS KFT. (Address: H-9600 Sárvár, Rábasömjéni utca 129., Hungary)
- Number of animals: not specified
- Characteristics of donor animals (e.g. age, sex, weight): 7 weeks old, age and sex not specified
- Storage, temperature and transport conditions of ocular tissue (e.g. transport time, transport media and temperature, and other conditions): After collection, the heads were inspected for appropriate quality and wrapped with tissue paper moistened with saline, then placed in a plastic box which was closed (4-5 heads per box) and transported at ambient temperature. The heads were received at Charles River Laboratories Hungary Kft. and processed within 2 hours of collection.
- Time interval prior to initiating testing: not specified
- indication of any existing defects or lesions in ocular tissue samples: none
- Indication of any antibiotics used: not specified
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied: 30mg - Duration of treatment / exposure:
- 10 seconds
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- None, however test material remained stuck to the cornea even after the 240minute post-treatment rinse.
- Number of animals or in vitro replicates:
- Three test item treated eyes, three positive control treated eyes and one negative control eye were examined during the study.
- Details on study design:
- SELECTION AND PREPARATION OF ISOLATED EYES
-selection: After removing the head from the plastic box, it was put on soft paper. The eyelids were carefully cut away with scissors, avoiding damaging the cornea. One small drop of 2% (w/v) fluorescein solution was applied onto the cornea surface for a few seconds and subsequently rinsed off with 20 mL physiological saline. Then the fluorescein-treated cornea was examined with a hand-held slit lamp or slit lamp microscope, with the eye in the head, to ensure that the cornea was not damaged (i.e. fluorescein retention and corneal opacity scores ≤ 0.5). If the cornea was in good condition, the eyeball was carefully removed from the orbit
-preparation:The eyeball was carefully removed from the orbit by holding the nictitating membrane with a surgical forceps, while cutting the eye muscles with bent scissors. Care was taken to remove the eyeball from the orbit without cutting off the optical nerve too short. The procedure avoided pressure on the eye while removing the eyeball from the orbit, in order to prevent distortion of the cornea and subsequent corneal opacity. Once removed from the orbit, the eye was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eyes were kept on the wet papers in a closed box so that the appropriate humidity was maintained.
EQUILIBRATION AND BASELINE RECORDINGS - At the end of the acclimatization period, a zero reference measurement was recorded for cornea thickness and opacity to serve as a baseline (t=0) for each individual eye. The cornea thickness of the eyes should not change by more than 5% within the -45 min and the zero time. No significant corneal thickness changes (1.6%) were observed in one eye and no corneal thickness changes were observed in the other eyes. Following the equilibration period, the fluorescein retention was measured. Baseline values were required to evaluate any potential test item related effect after treatment. All eyes were considered to be suitable for the assay.
NUMBER OF REPLICATES : 3
NEGATIVE CONTROL USED - yes
POSITIVE CONTROL USED - yes
APPLICATION DOSE AND EXPOSURE TIME - exposure time of 10s with the following:
-test substance treated chicken eye: treated with 30 mg cadmium oxide
-positive control chicken eye: treated with 30 mg imidazole
-negative control eye: treated with 30µL physiological saline (0.9% (w/v) NaCl solution
OBSERVATION PERIOD - The control eyes and test eyes were evaluated pre-treatment and at approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse. Minor variations within approximately ±5 minutes were considered acceptable.
REMOVAL OF TEST SUBSTANCE
- Volume and washing procedure after exposure period: cornea surface was rinsed thoroughly with 20ml physiological saline solution at ambient temperature. Additional gentle rinsing with 3x20 mL saline was performed at each time point when the test material or the positive control material remaining on the cornea was observed.
- Indicate any deviation from test procedure in the Guideline
METHODS FOR MEASURED ENDPOINTS:
- Corneal opacity: The cornea thickness and cornea opacity were measured at all time points (approximately 30, 75, 120, 180 and 240 minutes after the post-treatment rinse, minor variations within ±5 minutes considered acceptable)
- Damage to epithelium based on fluorescein retention: Fluorescein retention was measured on two occasions, at base line (t=0) and 30 minutes after the post-treatment rinse.
- Swelling: measured with optical pachymeter on a slit-lamp microscope; slit-width setting: not specified
- Macroscopic morphological damage to the surface: not observable
- Others (e.g, histopathology): performed, see results for report
SCORING SYSTEM:
- Mean corneal swelling (%) : according to ICE classification criteria for corneal thickness
- Mean maximum opacity score: according to ICE classification criteria
- Mean fluorescein retention score at 30 minutes post-treatment : according to ICE classification criteria
DECISION CRITERIA: please specify if the decision criteria as indicated in the TG was used. - yes
Results and discussion
In vitro
Resultsopen allclose all
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- up to 75 minutes
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- Physiological saline
- Positive controls validity:
- valid
- Remarks:
- Imidazole
- Remarks on result:
- not determinable because of methodological limitations
- Irritation parameter:
- percent corneal swelling
- Run / experiment:
- up to 240 minutes
- Value:
- 14.5
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- Physiological saline
- Positive controls validity:
- valid
- Remarks:
- Imidazole
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- cornea opacity score
- Value:
- 1.33
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- Physiological saline
- Positive controls validity:
- valid
- Remarks:
- Imidazole
- Remarks on result:
- positive indication of irritation
- Irritation parameter:
- fluorescein retention score
- Value:
- 1.83
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- Physiological saline
- Positive controls validity:
- valid
- Remarks:
- Imidazole
- Remarks on result:
- positive indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: Difficult to evaluate because the test item fully stuck the all cornea surfaces. The cornea swelling was not detected until 180 minutes observation and the cornea opacity until 120 minutes observation because of this reason.
HISTOPATH: The negative control (0.9 % Sodium chloride, Salsol solution) cornea showed no abnormalities. Positive control, 30 mg Imidazole was associated with severe epithelial erosion in 3/3 cases. Moderate pyknotic nuclei were observed in outer region of stroma in 3/3 cases. No endothelial changes were recorded. The test item, cadmium carbonate produced slight erosion of the corneal epithelium in 6/6 sections. Very slight vacuolation of the low part of the epithelium in 3/6 sections and slight vacuolation of the low part of the epithelium was noted in 2/6 sections. No stromal or endothelial changes were observed. Based on the published criteria for histopathological changes, the test item, cadmium oxide was classified as Category 1.
DEMONSTRATION OF TECHNICAL PROFICIENCY: not specified
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: Yes, classified as non-irritating, according to the EU regulations. UN GHS Classification: No Category.
- Acceptance criteria met for positive control: Yes, classified as severe irritant according to the EU regulations. UN GHS Classification: Category 1.
- Range of historical values if different from the ones specified in the test guideline: see historical data table in additional results section
Any other information on results incl. tables
The mean values of the treated eyes for maximum corneal thickness change, corneal opacity and fluorescein retention are given below. The conclusion on eye irritancy was based on the OECD guideline quantitative assessments.
The mean maximum corneal swelling up to 240 min, the mean maximum corneal opacity and the mean fluorescein retention ICE classes are used for EC and GHS classification.
Test item
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
not detected |
no data |
Mean maximum corneal swelling at up to 240 min |
14.5 % |
II |
Mean maximum corneal opacity |
1.33 |
II |
Mean fluorescein retention |
1.83 |
III |
Other Observations |
Test item was stuck on all cornea surfaces after the post-treatment rinse. The cornea surfaces were not cleared at 240 minutes after the post-treatment rinse. |
|
Overall ICE Class |
2xII 1xIII |
The cornea swelling was not detected until 180 minutes observation and the cornea opacity until 120 minutes observation because the test item fully stuck the all cornea surfaces. Based on this in vitro eye irritation study in isolated chicken eyes withCadmium oxide, the test item is not classified as a severe irritant and not classified as non-irritant. It is concluded that further information is required for classification.
Positive Control
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
9.2 % |
II |
Mean maximum corneal swelling at up to 240 min |
20.0 % |
III |
Mean maximum corneal opacity |
3.83 |
IV |
Mean fluorescein retention |
3.00 |
IV |
Other Observations |
Imidazole was stuck on all cornea surfaces after the post-treatment rinse. The cornea surfaces were not cleared at 240 minutes after the post-treatment rinse. |
|
Overall ICE Class |
1xIII 2xIV |
Based on these observations, the positive control substance Imidazole was classified as severe irritant according to the EU regulations. UN GHS Classification: Category 1.
Negative Control
Observation |
Value |
ICE Class |
Mean maximum corneal swelling at up to 75 min |
1.6 % |
I |
Mean maximum corneal swelling at up to 240 min |
1.6 % |
I |
Mean maximum corneal opacity |
0.00 |
I |
Mean fluorescein retention |
0.00 |
I |
Other Observations |
None |
|
Overall ICE Class |
3xI |
The negative control Physiological saline was classified as non-irritating,according to the EU regulations. UN GHS Classification:No Category.
Histopathology: microscopic findings:
Test Material |
Eye number
|
Epithelium |
Notes |
Stroma |
Endothelium |
|||||||||
Erosion |
Necrosis |
Vacuolation† |
Disorder of fibers
|
Pyknotic nuclei |
Necrosis |
|
||||||||
outer region (adjacent to epithelium) |
inner region (adjacent to endothelium) |
|
||||||||||||
Top |
Mid |
Low |
|
|||||||||||
Cadmium oxide |
14A |
1 |
- |
- |
- |
1 |
- |
- |
- |
- |
- |
|
||
14B |
1 |
- |
- |
- |
1 |
- |
- |
- |
- |
- |
|
|||
15A |
1 |
- |
- |
- |
½ |
- |
- |
- |
- |
- |
|
|||
15B |
1 |
- |
- |
- |
½ |
- |
- |
- |
- |
- |
|
|||
16A |
1 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
|||
16B |
1 |
- |
- |
- |
½ |
- |
- |
- |
- |
- |
|
|||
Imidazole |
17 |
3 |
- |
- |
- |
- |
- |
- |
2 |
- |
- |
|
||
18 |
3 |
- |
- |
- |
- |
- |
- |
2 |
- |
- |
|
|||
19 |
3 |
- |
- |
- |
- |
- |
- |
2 |
- |
- |
|
|||
NaCl 0.9% (w/v) Solution |
20 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Summary table for GHS classification:
Criteria for “No category” (all true) |
|
3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II or 1 endpoint classed as I and 2 endpoints classed as II: |
False |
No severe corneal morphological changes: |
False |
Test item was not stuck to the cornea at 240 minutes after the post-treatment rinse: |
False |
Criteria for “Category 1” (one or more true) |
|
2 or more endpoints classed as IV: |
False |
Corneal opacity ≥ 3 at 30 min (in at least 2 eyes): |
False |
Corneal opacity = 4 at any time point (in at least 2 eyes): |
False |
Severe loosening of epithelium (in at least 1 eye): |
False |
Criteria for “No prediction can be made” (one or two true) |
|
Based on the endpoints not classifiable for No Category, or for Category 1: |
True |
Particles of test item were stuck to the cornea and could not be washed off during the study: |
True |
Pathology report:
Score form histopathology chicken eyes
Test Material |
Chamber ID |
Epithelium |
Notes |
Stroma |
Endothelium |
Category |
|||||||
Erosion |
Necrosis |
Vacuolation† |
Disorder of fibers |
Pyknotic nuclei |
Necrosis |
||||||||
outer region (adjacent to epithelium) |
inner region (adjacent to endothelium) |
||||||||||||
Top |
Mid |
Low |
|||||||||||
Cadmium oxide |
14A |
1 |
- |
- |
- |
1 |
|
- |
- |
- |
- |
Category 1 |
|
14B |
1 |
- |
- |
- |
1 |
|
- |
- |
- |
- |
|||
Cadmium oxide |
15A |
1 |
- |
- |
- |
½ |
|
- |
- |
- |
- |
||
15B |
1 |
- |
- |
- |
½ |
|
- |
- |
- |
- |
|||
Cadmium oxide |
16A |
1 |
- |
- |
- |
- |
|
- |
- |
- |
- |
||
16B |
1 |
- |
- |
- |
½ |
|
- |
- |
- |
- |
Positive Control |
17 |
3 |
- |
- |
|
- |
- |
- |
2 |
- |
- |
Positive Control |
18 |
3 |
- |
- |
- |
- |
- |
- |
2 |
- |
- |
Positive Control |
19 |
3 |
- |
- |
- |
- |
- |
- |
2 |
- |
- |
Negative Control |
20 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Historical data:
|
Maximum corneal swelling at up to 75 min |
Maximum corneal swelling at up to 240 min |
Maximum corneal opacity change |
Fluoresccein retention change |
Number |
|||||||||
|
Min. Value |
Max. Value |
Mean |
SD |
Min. Value |
Max. Value |
Mean |
SD |
Min. Value |
Max. Value |
Min. Value |
Max. Value |
|
|
Negative control/ Physiological Saline |
||||||||||||||
Year 2014 |
-3.2% |
3.4% |
-0.3% |
1.1% |
-4.8% |
3.4% |
-0.6% |
1.5% |
0.0 |
0.5 |
0.0 |
0.5 |
115 |
|
Year 2015 |
-1.6% |
1.7% |
0.0% |
0.5% |
-1.6% |
3.2% |
0.0% |
0.7% |
0.0 |
0.5 |
0.0 |
0.0 |
126 |
|
Year 2016 |
-1.6% |
1.6% |
0.1% |
0.4% |
-3.2% |
1.7% |
0.1% |
0.7% |
0.0 |
0.0 |
0.0 |
0.0 |
76 |
|
Year 2017 |
0.0% |
0.0% |
0.0% |
0.0% |
-1.6% |
0.0% |
0.0% |
0.2% |
0.0 |
0.0 |
0.0 |
0.0 |
55 |
|
Year 2018 |
0.0% |
0.0% |
0.0% |
0.0% |
-1.6% |
1.6% |
0.0% |
0.4% |
0.0 |
0.0 |
0.0 |
0.0 |
58 |
|
Year 2019 |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1.7% |
0.0% |
0.2% |
0.0 |
0.0 |
0.0 |
0.0 |
49 |
|
Year 2020 |
-1.6% |
1.6% |
-0.2% |
0.9% |
-3.2% |
1.6% |
-0.5% |
1.3% |
0.0 |
0.0 |
0.0 |
0.0 |
10 |
|
Period 2014-2020 |
-3.2% |
3.4% |
0.0% |
0.6% % |
-4.8% |
3.4% |
-0.1% |
0.9% |
0.0 |
0.5 |
0.0 |
0.5 |
489 |
|
Positive control/Benzalkonium Chloride |
||||||||||||||
Year 2014 |
-7.7% |
27.0% |
5.9% |
8.9% |
-10.7% |
34.8% |
12.3% |
13.8% |
2.5 |
4.0 |
1.5 |
3.0 |
186 |
|
Year 2015 |
-7.9% |
20.0% |
9.7% |
4.5% |
15.9% |
38.3% |
27.7% |
3.6% |
3.0 |
4.0 |
2.5 |
3.0 |
246 |
|
Year 2016 |
-4.8% |
16.7% |
10.3% |
2.4% |
19.4% |
33.3% |
27.2% |
2.6% |
4.0 |
4.0 |
3.0 |
3.0 |
141 |
|
Year 2017 |
-4.8% |
15.0% |
9.5% |
2.7% |
20.6% |
31.7% |
25.7% |
2.6% |
4.0 |
4.0 |
3.0 |
3.0 |
78 |
|
Year 2018 |
6.3% |
14.5% |
10.0% |
1.9% |
20.6% |
35.5% |
27.2% |
2.9% |
3.5 |
4.0 |
2.5 |
3.0 |
99 |
|
Year 2019 |
4.8 % |
16.4% |
9.8% |
2.2% |
17.7% |
36.1% |
27.5% |
3.6% |
4.0 |
4.0 |
2.5 |
3.0 |
72 |
|
Year 2020 |
6.6% 11.7% 9.0% 1.5% 17.7% 36.1% 27.9% 3.5% 4 4.0 2.5 3.0 6 |
11.7% 9.0% 1.5% 17.7% 36.1% 27.9% 3.5% 4 4.0 2.5 3.0 6 |
9.2% |
1.6% |
17.7% |
25.4% |
21.6% |
2.3% |
3.5 |
4.0 |
2.5 |
3.0 |
21 |
|
Period 2014-2020 |
-7.9% |
27.0% |
9.0% |
5.3% |
-10.7% |
38.3% |
23.8% |
9.4% |
2.5 |
4.0 |
1.5 |
3.0 |
843 |
|
Positive control/Imidazole |
||||||||||||||
Year 2014 |
-6.6% |
25.0% |
7.1% |
6.1% |
-15.9% |
35.4% |
14.6% |
8.7% |
3.5 |
4.0 |
2.0 |
3.0 |
160 |
|
Year 2015 |
6.3% |
19.7% |
11.5% |
2.8% |
20.0% |
36.7% |
28.7% |
3.5% |
3.5 |
4.0 |
2.5 |
3.0 |
130 |
|
Year 2016 |
4.8% |
15.0% |
10.3% |
1.9% |
18.8% |
33.3% |
26.9% |
2.7% |
4.0 |
4.0 |
3.0 |
3.0 |
90 |
|
Year 2017 |
4.8% |
16.7% |
10.4% |
2.2% |
20.6% |
33.3% |
26.1% |
2.6% |
4.0 |
4.0 |
3.0 |
3.0 |
87 |
|
Year 2018 |
6.3% |
13.3% |
10.6% |
1.8% |
21.9% |
31.7% |
26.9% |
2.5% |
4.0 |
4.0 |
3.0 |
3.0 |
78 |
|
Year 2019 |
6.3% |
16.4% |
10.7% |
2.1% |
23.8% |
34.4% |
28.1% |
2.3% |
4.0 |
4.0 |
2.5 |
3.0 |
81 |
|
Year 2020 |
8.1% |
13.3% |
9.6% |
1.7% |
17.7% |
25.0% |
21.1% |
2.1% |
3.5 |
4.0 |
2.5 |
3.0 |
9 |
|
Period 2014-2020 |
-6.6% |
25.0% |
9.8% |
4.0% |
-15.9% |
36.7% |
24.1% |
7.5% |
3.5 |
4.0 |
2.0 |
3.0 |
635 |
CONCLUSION
Semi-quantitative microscopic evaluation was performed on the cornea in the ICET. The classification of histopathology findings was performed based on the publications:M.K. Prinsen et al./Toxicology in Vitro 25 (2011), 1475-1479), Elodie Cazelle et al./ Toxicology in Vitro 28 (2014), 657-666 and Atlas of histopathological lesions of Isolated Chicken Eyes, M.V.W. Wijnands and M.K. Prinsen, June 2015.
The negative control, 30 µL of0.9 % Sodium chloride (Salsol solution)cornea showed no abnormalities.Positive control, 30 mg of Imidazole caused severe epithelial erosion of corneal epithelium in 3/3 cases. Moderate presence of pyknotic nuclei in top region of stroma in 3/3 cases.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Conclusions:
- Based on the performed in vitro eye irritation assay in isolated chicken eyes with Cadmium oxide, the test item is not classified as a severe irritant and not classified as non-irritant. It is concluded that further information is required for classification.
Histopathological observations were made on two sections of each of the 3 corneas treated with test item (6 sections). Microscopic evaluation showed slight erosion of the corneal epithelium in 6/6 cases. Very slight vacuolation of the low part of the epithelium in 3/6 sections and slight vacuolation of the low part of the epithelium was noted in 2/6 sections. No stromal or endothelial changes were observed as well as no effects on integrity of basement, Bowman’s and Descemet’s membranes. Based on the published criteria for histopathological changes, Cadmium oxide was classified as Category 1. - Executive summary:
An in vitro eye irritation study of the test item was performed in isolated chicken’s eyes. The irritation effects of the test item were evaluated according to the OECD No. 438 guideline (25 June 2018). After the zero reference measurements, the eyes were held in a horizontal position and the test item was applied onto the centre of the cornea such that the entire surface of the cornea was covered in all cases. After 10 seconds exposure time, the surface of the eyes was rinsed with physiological saline solution. Three eyes were treated with 30 mg test item. The three positive control eyes were treated in a similar way with 30 mg of Imidazole. The negative control eye was treated with 30 µL of physiological saline(0.9% (w/v) NaCl solution). Corneal thickness, corneal opacity and fluorescein retention were measured and any morphological effects (e.g. pitting or loosening of the epithelium) were evaluated.
The results from all eyes used in the study met the quality control standards. The negative control and positive control results were within the historical control data range in experiment. Thus, the study was considered to be valid.
Slight corneal swelling change (mean = 14.5%) was observed during the four-hour observation period on test item treated eyes. Slight cornea opacity change (severity 1 on two eyes and severity 2 on one eye) was observed on three eyes. Moderate fluorescein retention change (severity 2 on two eyes and severity 1.5 on one eye) was noted on three eyes. The cornea swelling was not detected until 180 minutes observation and the cornea opacity until 120 minutes observation because the test item fully stuck the all cornea surfaces. Test item was stuck on all cornea surfacesafter the post-treatment rinse. The cornea surfaces were not cleared at 240 minutes after the post-treatment rinse.
Based on this in vitro eye irritation assay in isolated chicken eyes with
Cadmium oxide, the test item is not classified as a severe irritant and not classified as non-irritant. It is concluded that further information is required for classification.Histopathological observations were made on two sections of each of the 3 corneas treated with test item (6 sections). Microscopic evaluation showed slight erosion of the corneal epithelium in 6/6 cases.Very slight vacuolation of the low part of the epithelium in 3/6 sections and slight vacuolation of the low part of the epithelium was noted in 2/6 sections. No stromal or endothelial changes were observed as well as no effects on integrity of basement, Bowman’s and Descemet’s membranes. Based on the published criteria for histopathological changes, Cadmium oxide was classified as Category 1.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.